Monocyte-to-Macrophage Trajectories After Lung Injury: Spatio-temporal investigation, molecular regulation & functional implications for lung regeneration and immunity
This project aims to elucidate the diverse roles and regulatory mechanisms of inflammatory monocyte-derived macrophages in lung injury and repair, using advanced mouse models and human organoid systems.
Projectdetails
Introduction
The lung is particularly exposed to airborne and blood-borne insults. The mechanisms underlying lung tissue repair are therefore of fundamental biological importance and have critical implications for the prevention of life-threatening inflammatory and tissue-damaging responses.
Key Players in Lung Repair
Lung-resident tissue macrophages and inflammatory monocyte-derived macrophages (InfMoMac) are key players in the maintenance of homeostasis, repair responses, and disease pathogenesis. Yet, to date, the complexity of lung macrophage responses after injury is far from being resolved.
Research Objectives
Here, we propose to explore InfMoMac trajectories and functional diversity in an unprecedented manner. To this end, we will use:
- Mouse models of infectious and non-infectious lung injury
- Single cell and spatial analyses
- Robust fate-mapping models
- Gene targeting approaches
These methods will help us investigate:
- The spatio-temporal regulation
- The subtissular niches
- The intrinsic molecular programs
- The extrinsic stress-, inflammation-, and niche-related signals imprinting the identities and functions of InfMoMac subpopulations
Functional Consequences
We will also examine the functional consequences of the maintenance of InfMoMac for lung immunity to a subsequent challenge.
Human Studies
Finally, we will investigate the interactions of InfMoMac with niche cells in humans by:
- Analyzing the InfMoMac landscape in human injured lungs
- Studying a novel human embryonic stem cell-derived lung organoid model in co-culture with monocyte-derived cells
Conclusion
Based on robust preliminary data, sophisticated models, and cutting-edge technologies, this ambitious project will increase our understanding of the basic mechanisms underlying the fine-tuning of InfMoMac trajectories in response to lung injuries. It will thus provide robust foundations to manipulate their fate in medically relevant conditions such as severe respiratory viral infections and acute respiratory distress syndrome.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.999.863 |
Totale projectbegroting | € 1.999.863 |
Tijdlijn
Startdatum | 1-1-2025 |
Einddatum | 31-12-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- UNIVERSITE DE LIEGEpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Moving cell-based immunotherapies to fight bacterial lung infections into the clinicsiMAClung aims to develop an immune cell-based therapy using induced pluripotent stem cell-derived macrophages to combat bacterial airway infections and enhance lung regeneration. | ERC Proof of... | € 150.000 | 2024 | Details |
Dissecting Macrophage Mechanobiology to Engineer Immuno-Regenerative BiomaterialsMACxercise aims to enhance implant integration by investigating how macrophages respond to mechanical cues in bioresorbable biomaterials, fostering advancements in tissue regeneration. | ERC Starting... | € 1.499.950 | 2022 | Details |
Overcoming Monocyte Complexity in Pulmonary Fibrosis Progression from Onset to End-StageOMEGA aims to identify early mechanisms and therapeutic targets in progressive pulmonary fibrosis by studying monocyte subtypes and interstitial lung abnormalities from early to advanced disease stages. | ERC Starting... | € 1.499.459 | 2025 | Details |
Dissection of Microglial State Biology in Brain RepairThis project aims to elucidate the dynamics and functions of microglial states during brain repair using a spatiotemporal atlas and novel molecular tools to enhance understanding of neuroinflammation. | ERC Starting... | € 1.684.803 | 2024 | Details |
Tracking adaptation of naïve T cells to distinct organs to decode organ-specific immune diseasesThis project investigates how organ-adapted naïve CD4+ T cells contribute to organ-specific immune-mediated inflammatory diseases triggered by environmental factors, aiming to enhance precision medicine approaches. | ERC Consolid... | € 1.999.000 | 2024 | Details |
Moving cell-based immunotherapies to fight bacterial lung infections into the clinics
iMAClung aims to develop an immune cell-based therapy using induced pluripotent stem cell-derived macrophages to combat bacterial airway infections and enhance lung regeneration.
Dissecting Macrophage Mechanobiology to Engineer Immuno-Regenerative Biomaterials
MACxercise aims to enhance implant integration by investigating how macrophages respond to mechanical cues in bioresorbable biomaterials, fostering advancements in tissue regeneration.
Overcoming Monocyte Complexity in Pulmonary Fibrosis Progression from Onset to End-Stage
OMEGA aims to identify early mechanisms and therapeutic targets in progressive pulmonary fibrosis by studying monocyte subtypes and interstitial lung abnormalities from early to advanced disease stages.
Dissection of Microglial State Biology in Brain Repair
This project aims to elucidate the dynamics and functions of microglial states during brain repair using a spatiotemporal atlas and novel molecular tools to enhance understanding of neuroinflammation.
Tracking adaptation of naïve T cells to distinct organs to decode organ-specific immune diseases
This project investigates how organ-adapted naïve CD4+ T cells contribute to organ-specific immune-mediated inflammatory diseases triggered by environmental factors, aiming to enhance precision medicine approaches.